Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ziopharm Oncology IN (ZIOP)

Ziopharm Oncology IN (ZIOP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ziopharm Oncology to Participate in Upcoming Conferences

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), a clinical-stage cellular therapy company focused on hematologic and solid tumor cancers, today announced that Company management will...

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting

- Highlighted distinctive cellular therapy program, market opportunity and value proposition

ZIOP : 2.81 (-4.75%)
Ziopharm: Q1 Earnings Snapshot

BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Thursday reported a loss of $21.6 million in its first quarter.

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates

- Annual shareholder meeting planned for May 19, 2021

ZIOP : 2.81 (-4.75%)
ZIOPHARM Oncology, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM...

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley '21 Two-Day Live Virtual Educational Symposium

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today that Laurence J.N. Cooper, PhD, MD, Scientific Advisor to the Company, will present and participate in an upcoming...

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology to Report First Quarter Financial Results on May 6, 2021

Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced it will report first quarter 2021 financial results on Thursday, May 6, 2021 after the financial markets close, and host its annual shareholder meeting...

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Scientific Advisor Laurence J. N. Cooper, PhD, MD, Presented Today at Aldevron's Virtual Breakthrough Speakers Series

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today that Laurence J.N. Cooper, PhD, MD, Scientific Advisor to the Company, was the inaugural presenter at Aldevron's Virtual...

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today that in March, the first patient was infused in the CD19-Specific Rapid Personalized Manufacturing ("RPM") CAR-T Phase...

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today it will be presenting a poster at the upcoming American Association for Cancer Research (AACR) Virtual 2021 Annual...

ZIOP : 2.81 (-4.75%)
92.4% Return Seen to Date on SmarTrend Ziopharm Oncolog Call (ZIOP)

SmarTrend identified an Uptrend for Ziopharm Oncolog (NASDAQ:ZIOP) on November 11th, 2020 at $2.65. In approximately 4 months, Ziopharm Oncolog has returned 92.44% as of today's recent price of $5.09....

ZIOP : 2.81 (-4.75%)
Ziopharm Oncolog Shares Up 95.8% Since SmarTrend's Buy Recommendation (ZIOP)

SmarTrend identified an Uptrend for Ziopharm Oncolog (NASDAQ:ZIOP) on November 11th, 2020 at $2.65. In approximately 4 months, Ziopharm Oncolog has returned 95.84% as of today's recent price of $5.18....

ZIOP : 2.81 (-4.75%)
Ziopharm: 4Q Earnings Snapshot

BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Thursday reported a loss of $22.8 million in its fourth quarter.

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results

Heidi Hagen Appointed Interim Chief Executive Officer Replacing Dr. Laurence Cooper; Search for Permanent CEO Initiated

ZIOP : 2.81 (-4.75%)
ZIOPHARM Oncology, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021...

ZIOP : 2.81 (-4.75%)
Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients

, /PRNewswire/ -- Ovarian cancer and its rising incidence rate is a growing concern worldwide and the rising incidence of ovarian cancer will be driving the ovarian cancer drugs market for years to come....

BIOV.CN : 0.255 (-7.27%)
LMNGF : 0.2405 (-7.00%)
ONTX : 7.07 (-6.48%)
ZIOP : 2.81 (-4.75%)
EVFM : 1.2000 (-9.77%)
NKTR : 17.46 (-1.24%)
Ziopharm Oncolog Has Returned 103.4% Since SmarTrend Recommendation (ZIOP)

SmarTrend identified an Uptrend for Ziopharm Oncolog (NASDAQ:ZIOP) on November 11th, 2020 at $2.65. In approximately 3 months, Ziopharm Oncolog has returned 103.40% as of today's recent price of $5.38....

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021

Ziopharm Oncology, Inc. (the "Company") (Nasdaq: ZIOP), today announced the Company will host a conference call and webcast to discuss financial results for the fourth quarter and full year 2020 on Thursday,...

ZIOP : 2.81 (-4.75%)
Shares of ZIOP Up 98.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Ziopharm Oncolog (NASDAQ:ZIOP) on November 11th, 2020 at $2.65. In approximately 3 months, Ziopharm Oncolog has returned 98.49% as of today's recent price of $5.25....

ZIOP : 2.81 (-4.75%)
Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors

Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors (the "Board"), effective immediately. Mr. Postma is the Founder...

ZIOP : 2.81 (-4.75%)

Barchart Exclusives

Focus On Rare Earth Metals- This Week In Metals
This week, we take a look at the events in the rare earth metals markets, the commodities of tomorrow. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar